Kompleksnyy podkhod k lecheniyu ozhireniyai metabolicheskogo sindroma u muzhchin
https://doi.org/10.14341/2071-8713-4877
Abstract
There is abdominal obesity in men that is accompanied with high risk of concomitant disease. The different authors data about
close relation between obesity and metabolic syndrome with hypogonadism in men are performed in this article. Reduction of body
weight due to the treatment with Xenical is accompanied by improvement of metabolic syndrome symptoms.
close relation between obesity and metabolic syndrome with hypogonadism in men are performed in this article. Reduction of body
weight due to the treatment with Xenical is accompanied by improvement of metabolic syndrome symptoms.
References
1. Андрология. Мужское здоровье и дисфункция репродуктивной системы // Под ред. Э. Нишлага, Г.М. Бере. М.; 2005; 554 с.
2. Бутрова С.А. Лечение ожирения // Материалы 1-го Московского съезда эн- докринологов: Современные концепции клинической эндокринологии. М.; 1997; 172-77.
3. Григорьев П.Я., Исаков В.А., Яковенко Э.П. Патогенетические основы али- ментарного ожирения // Тер. архив. 1989; 61(9): 120-25.
4. Ивлева А.Я., Старостина Е.Г. Ожирение - проблема медицинская, а не кос- метическая // М.; 2002; 22.
5. Калинченко С.Ю., Роживанов Р.В. Особенности лечения ожирения у муж- чин // Ожирение и метаболизм, 2005.
6. Татонь Я. Ожирение: патофизиология, диагностика, лечение // М.: Медицина, 1981; 363 с.
7. Угланова Т.М. Патогенез, классификация и терапия ожирения // Сб. науч. труд.: Патология метаболизма: атеросклероз, ожирение, сахарный диабет. - Нижний Новгород, 1992; 83-91.
8. American Diabetes Association. Management of Dyslipidemia in Adults With Diabetes. Position Statement // J. Diabetes. Care. 1999; 22: 9-56.
9. Anderson К.A., Costelli W.R, Levy D. // J. Amer. med. Assoc. 1987; 257: 2176-80.
10. Armellini et al. Hormones and body composition in humans: clinical studies // Int. J. Obes. Relat. Metab. Disord. 2000; 24(2): 18-21.
11. Bjorntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? // J. Intern. Med. 1991; 230: 195-201.
12. Cunningham G.R. Management of male aging: which testosterone replacement therapy should be used? // The Aging Male. 2000; 3: 203-9.
13. Dobs et al. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation- enhanced testosterone transdermal system // J. Clin. Endocrinol. Metab. 2001; 86(3): 1026-33.
14. Grundy S.M. Multifactorial causation of obesity: implications for prevention // Am. J. Clin. Nutr. 1998; 67(1): 563S-572S.
15. Hak et al. Тhe Rotterdam study, Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study // J. Clin. Endocrinol. Metab. 2002; 87(8): 3632-9.
16. Haffner S.M., Miettinen H., Mykkanen L., Stern M.P. Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/ insulin ratio in non-diabetic subjects // Int. J. Obes. Relat. Metab. Disord. 1998; 22(9): 899-905.
17. Hennes S., Perry C.M. Orlistat. Drugs 2006; 66(12): 1625-56.
18. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K. DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women // Arch. Intern. Med. 2004; 164(10): 1066-76.
19. Imoberdorf R. Ballmer P.E. Obesity: principles of drug therapy // Ther. Umsch. 2000; 57 (8): 522-5.
20. Isomaa B., Almgren P., Tuomi T., Forsйn B., Lahti K., Nissйn M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome // Diabetes Care. 2001; 24(4): 683-9.
21. Katznelson et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism // J. Clin. Endocrinol. Metab. 1996; 81(12): 4358-65.
22. Kendall D.M., Sobel B.E., Coulston A.M. The insulin resistance syndrome and coronary artery disease // Coron. Artery. Dis. 2003; 14(4): 335-48.
23. Kissebah A.H., Evans D.J., Peiris A., Wilson C.R. Endocrine characteristics in regional obesities role of sex steroids // Excerpta Medica. - Amsterdam. 1985; 115-30.
24. Kissebah A.H., Krakower G.R. Regional adiposity and morbidity // Physiol. Rev. 1994; 74: 761-811.
25. Laaksoner D.E., Lokka H.M. et al. // Am. J. Epidemiol. 2002; 156: 1070-7.
26. Laaksoner D.E. et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study // Eur. J. Endocrinol. 2003; 149(6): 601-8.
27. Leenen R., van der Kooy K., Seidell J.C. et al. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy // J. Clin. Endocrinol. Metab. 1994; 78: 1515-20.
28. Levine A.S., Giraudo S.Q., Kotz С.М. Billington C.J. Neuropeptides: regulators of energy-, stress- and «reward»-induced feeding // Int. J. of Obes. 2000; 24(l): S6.
29. Marin P., Holmang S., Jonsson L., Sjostrom L., Kvist H., Holm G., Lindstedt G., Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men // Int. J. Obesity. 1992; 16: 991-7.
30. Marin P., Arver S. Androgens and abdominal obesity // Baillieres. Clin. Endocrinol. Metab. 1998; 12(3): 441-51.
31. Pasquali R., Casimirri F., De Iasio R., Mesini P. et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men // J. Clin. Endocrinol. Metab. 1995; 80: 654-8.
32. Phillips G.B., Pinkernell B.H., Jing T.Y. The association of hypotestosteronemia with coronary artery disease in men // Arterioscler Thromb. 1994; 14(5): 701-6.
33. Roncavi D.A.K., Van R.L.R. Promotion of human adipocite precursor replication by 17β-estradiol in culture // J. Clin. Invest. 1977; 62: 503-8.
34. Seidell J.S. The worldwide epidemic of obesity. In: Progress in obesity research. 8th International congress on obesity. Guy-Grand B., Ailhaud G. eds. London. 1999.
35. Simon et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study // J. Clin. Endocrinol. Metab. 1997; 82(2): 682-5.
36. Stellato R.K., Feldman H.A., Hamdy O., Horton E.S., McKinlay J.B. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle- aged men: prospective results from the Massachusetts male aging study // Diabetes Care. 2000; 23(4): 90-494.
37. Suter P.M., Vetter W. Drug therapy of obesity. Strategies for general practice // Schweiz Rundsch Med Prax. 2000; 89 (14): 575-85.
38. Svartberg J. et al. Waist circumference and testosterone levels in community dwelling men. The Tromsї study // Europ. J. Epidemiol. 2004; 19(7): 657-63.
39. Tsai E.C., Boyko E.J., Leonetti D.L., Fujimoto W.Y. Low serum testosterone level as predictor of increased visceral fat in Japanese-American men // Int. J. Obes. Relat. Metab. Disord. 2000; 24: 485-91.
40. Wang C. et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men // J. Clin. Endocrinol Metab. 2000; 85(8): 2839-53.
41. Weiss D. How to help your patients lose weight: current therapy for obesity // Cleve. Clin. J. Med. 2000; 67(10): 739, 743-6, 749-754.
Review
For citations:
, , , Kompleksnyy podkhod k lecheniyu ozhireniyai metabolicheskogo sindroma u muzhchin. Obesity and metabolism. 2009;6(4):38-41. (In Russ.) https://doi.org/10.14341/2071-8713-4877
Views:
666
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
